Home › Funds › PSP Research LLC › MDGL

PSP Research LLC position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

PSP Research LLC reported holding 600 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$302K, representing 0.21% of its reported portfolio and ranking #5 among its reported holdings. PSP Research LLC has disclosed MDGL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)600 sh
Reported value held$302.38K
Portfolio Weight0.21%
First reportedQ4 2025
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's MDGL position evolved

PSP Research LLC first disclosed a stake in MDGL in Q4 2025 at 892 shares (US$519K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 600 shares valued at US$302K. Notable position changes include a 33% trim in Q1 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 892 $519.45K New
Q1 2026 600 $314.08K Reduce
Q2 2026 600 $322.17K Hold
Q3 2026 600 $302.38K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has PSP Research LLC held MDGL?

PSP Research LLC has disclosed MDGL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in MDGL?

As of Q3 2026, PSP Research LLC holds 600 shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $302.38K, representing 0.21% of its reported portfolio and ranking #5.

Has PSP Research LLC been buying or selling MDGL?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in MDGL.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.